North America Infraglottic Devices Market Outlook (2022-2033)

The North America Infraglottic Devices market size is expected to reach US$ 2,129.7 million by 2033 from US$ 1,340.4 million in 2025. The market is estimated to record a CAGR of 11.1% from 2026 to 2033.

Executive Summary and North America Infraglottic Devices Market Analysis:

The market of North American infraglottic devices is highly matured and technically advanced, owing to the growing number of surgeries, critical care needs, and the incidence of chronic respiratory disorders. Various kinds of infraglottic devices, such as endotracheal and tracheostomy tubes, are extensively utilized within hospitals, ambulatory surgical centers, and EMSs. The focus on patient safety, infection control measures, and the following of strict clinical protocols in the region makes it conducive to the use of advanced airway management devices that are also disposable. Moreover, rising awareness regarding the need for early intervention in case of respiratory distress and airway management in emergencies has increased the market demand as well.

In spite of extensive implementation, there are certain issues that limit market growth, including the expensive nature of modern airway devices and the increasing requirement to equip healthcare practitioners with up-to-date intubation skills. Nonetheless, sustained R&D efforts along with the involvement of prominent homegrown and foreign players in the industry guarantee consistent innovations and access to cutting-edge infraglottic equipment. The backing of governments, via healthcare schemes and insurance plans for surgical and critical care operations, further aids in improving accessibility and fueling constant demand within North America.

North America Infraglottic Devices Market - Strategic Insights:

North America Infraglottic Devices Market Segmentation Analysis:

Key segments that contributed to the derivation of the North America infraglottic devices market analysis are product type, product design, application, patient type, and end user.

• By product type, the infraglottic devices market is segmented into endotracheal tubes, tracheostomy tubes, and endobronchial tubes. The endotracheal tubes segment dominated the market in 2025.
• Among product design, the infraglottic devices market is segmented into cuffed devices and uncuffed devices. The cuffed devices segment dominated the market in 2025.
• Based on application, the infraglottic devices market is segmented into anesthesia, critical care, emergency medicine, and other applications. The anesthesia segment dominated the market in 2025.
• In terms of patient type, the infraglottic devices market is segmented into adult and pediatric. The adult segment dominated the market in 2025.
• By end user, the infraglottic devices market is segmented into hospitals, ambulatory surgical centers, emergency medical services, and other end users. The hospitals segment dominated the market in 2025.

North America Infraglottic Devices Market Drivers and Opportunities:

Increasing Incidence of Respiratory Disorders

The North America infraglottic devices market is primarily driven by the high and rising prevalence of chronic and acute respiratory illnesses across a heavily aging population. In the United States and Canada, Chronic Obstructive Pulmonary Disease (COPD) remains a leading cause of disability, fueled by decades of tobacco use and increasing environmental triggers in urban centers. Furthermore, the region is seeing a significant uptick in acute respiratory distress cases and severe pneumonia, which frequently require intensive care admissions and prolonged mechanical ventilation. As hospitals in this region maintain some of the highest intensive care unit (ICU) capacities globally, the demand for reliable infraglottic tools—specifically endotracheal and tracheostomy tubes—remains a fundamental necessity for managing these critically ill patients and ensuring airway stability.

In addition to chronic conditions, the growth is heavily supported by the volume of complex surgical procedures and a robust emergency medical services (EMS) infrastructure. North America leads the world in advanced cardiothoracic and neurological surgeries, all of which necessitate sophisticated airway management during and after the operation. The high incidence of trauma-related emergencies, such as road traffic accidents and acute cardiac events, also places a constant demand on first responders and emergency departments for rapid-insertion infraglottic solutions. With a well-established reimbursement framework and high healthcare spending, providers are empowered to maintain high inventory levels of these life-saving devices, ensuring that respiratory health remains a top priority in the regional clinical landscape.

Advancement of Innovative and Patient-Friendly Devices

The North American market offers a substantial opportunity for the deployment of next-generation infraglottic devices that prioritize both clinical precision and patient comfort. There is an aggressive shift toward devices manufactured from advanced, biocompatible materials like medical-grade silicone and specialized polyurethanes, which are designed to reduce the risk of tracheal mucosal injury and long-term scarring. These innovations are particularly relevant in the United States, where there is a strong emphasis on reducing hospital-acquired infections, such as Ventilator-Associated Pneumonia (VAP). By introducing features like subglottic suction lumens and ultra-soft cuffs, manufacturers can cater to high-end medical facilities that are focused on improving patient outcomes and shortening hospital stays through “gentler” airway management.

Furthermore, the integration of digital technology and artificial intelligence into airway management tools represents a major technological frontier in the region. North America is at the forefront of adopting smart infraglottic devices equipped with integrated sensors and video-assisted capabilities that allow for real-time monitoring of tube placement and cuff pressure. These advancements are highly attractive to large hospital networks looking to minimize human error and enhance procedural safety. Additionally, the growing trend toward specialized single-use and portable infraglottic kits provides a strategic opening in the expanding home-care and ambulatory surgery markets. Companies that focus on developing intuitive, high-performance devices that align with the region's push for "value-based" healthcare will find significant opportunities for long-term growth and market leadership.

North America Infraglottic Devices Market Size and Share Analysis:

The North America infraglottic devices market is experiencing steady growth, with market size and share analysis reflecting evolving treatment preferences and competitive dynamics among key players. The report evaluates important subsegments categorized within product type, product design, application, patient type, and end user, highlighting their respective contributions to overall market performance.

By product type, the endotracheal tubes subsegment dominated the market in 2025 due to their widespread use in airway management during surgeries, critical care, and emergency settings, offering reliable ventilation support and ease of insertion across diverse clinical scenarios.

Among product design, the cuffed devices subsegment dominated the market in 2025 due to their ability to provide effective airway sealing, prevent aspiration, and enable controlled ventilation, making them highly preferred in intensive care and surgical procedures requiring precise airway management.

Based on application, the anesthesia subsegment dominated the market in 2025 due to the high volume of surgical procedures requiring airway management, consistent use of endotracheal tubes during general anesthesia, and increasing demand for safe and controlled ventilation in operating rooms.

In terms of patient type, the adult subsegment dominated the market in 2025 due to higher incidence of chronic respiratory diseases, greater number of surgical procedures, and increased hospitalization rates requiring airway management and ventilatory support in adult populations.

By end user, the hospitals subsegment dominated the market in 2025 due to availability of advanced infrastructure, high patient inflow, presence of intensive care units, and continuous requirement for airway management devices during surgeries and emergency treatments.

North America Infraglottic Devices Market Report Highlights:

North America Infraglottic Devices Market Report Coverage and Deliverables:

The "North America Infraglottic Devices Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• North America Infraglottic Devices market size and forecast at regional and country levels for all market segments covered under the scope
• North America Infraglottic Devices market trends, as well as drivers, restraints, and opportunities
• North America Infraglottic Devices market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the North America Infraglottic Devices market
• Detailed company profiles, including SWOT analysis

North America Infraglottic Devices Market Geographic Insights:

The geographical scope of the North America Infraglottic Devices market report is divided into: The US, Canada, and Mexico. The US held the largest share in 2025.

The United States dominates the North America infraglottic devices market due to its large, technologically advanced healthcare system, extensive network of hospitals, and high surgical volumes. Infraglottic devices are integral in anesthesia, intensive care, and emergency medicine, with hospitals emphasizing both patient safety and procedural efficiency. Rising cases of chronic respiratory conditions, trauma, and critical care admissions contribute to sustained demand for advanced airway management devices.

The country benefits from a mature medical device industry and a robust supply chain, allowing access to cutting-edge and disposable infraglottic products. Training programs for anesthesiologists and critical care professionals further improve device utilization across hospital and pre-hospital settings. While the high cost of innovative devices can limit adoption in smaller healthcare facilities, strong government healthcare initiatives, insurance coverage, and hospital investment in modern ICUs ensure widespread access. Ongoing technological innovation, focus on minimally invasive airway management techniques, and emphasis on patient safety position the United States as the dominant contributor to the North America infraglottic devices market.

North America Infraglottic Devices Market Research Report Guidance:

• The report includes qualitative and quantitative data in the North America Infraglottic Devices market across product type, product design, application, patient type, end user, and geography.

• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the North America Infraglottic Devices market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the North America Infraglottic Devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the North America Infraglottic Devices market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 10 cover the North America Infraglottic Devices market segments by product type, product design, application, patient type, end user, and geography across the US, Canada, and Mexico. They cover the market revenue, forecast, and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the North America Infraglottic Devices market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

North America Infraglottic Devices Market News and Key Development:

The North America Infraglottic Devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the North America Infraglottic Devices market are:

• In July 2024, Medtronic plc announced that it issued an urgent global recall and removal from inventory of all NIM™ Standard and Contact EMG reinforced endotracheal tubes sold in the U.S. and other regions due to risk of airway obstruction, advising healthcare providers to stop use and return affected products.
• In June 2023, Teleflex Incorporated announced that it was awarded national group purchasing agreements with Premier Inc. in the United States, enabling broader access and special pricing for its Rüsch™ and Sheridan™ endotracheal tubes and other airway products to ~4,400 hospitals and healthcare systems.

Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• American Thoracic Society
• European Respiratory Society (ERS)
• American Society of Anesthesiologists (ASA)
• Society of Critical Care Medicine
• International Anesthesia Research Society (IARS)
• World Federation of Societies of Anaesthesiologists (WFSA)
• Company Websites
• Company Annual Reports
• Company Investor Presentations